Emmaus Life Sciences, Inc.
EMMA
$0.0115
-$0.0024-17.27%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 51.29% | -33.30% | -195.68% | 183.65% | 49.77% |
| Total Depreciation and Amortization | -20.00% | 0.00% | 0.00% | -16.67% | 0.00% |
| Total Amortization of Deferred Charges | 29.29% | 30.26% | 10.14% | 0.00% | -86.03% |
| Total Other Non-Cash Items | -495.06% | 122.82% | 63.31% | -200.26% | 4,120.83% |
| Change in Net Operating Assets | -153.99% | -13.86% | 1,394.51% | 106.65% | -167.84% |
| Cash from Operations | -1,142.29% | -18.66% | 131.76% | 105.07% | -2,183.57% |
| Capital Expenditure | -- | -- | -700.00% | 133.33% | 25.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Investing | -- | -- | -300.00% | -99.96% | 62,725.00% |
| Total Debt Issued | 68.49% | 32.53% | 13.75% | -20.08% | -28.50% |
| Total Debt Repaid | -12.70% | -40.36% | 10.74% | -61.62% | 67.47% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 182.32% | -76.92% | 55.48% | -286.38% | 124.61% |
| Foreign Exchange rate Adjustments | -50.00% | 183.33% | -163.16% | 290.00% | 37.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -700.00% | -141.79% | 149.63% | -44.39% | 77.60% |